ArticleCancer immunology research2026

Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming.

Phaethon Philbrook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.